Edrophonium chloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for edrophonium chloride and what is the scope of patent protection?
Edrophonium chloride
is the generic ingredient in six branded drugs marketed by Hospira, Watson Labs, Mylan Institutional, Organon Usa Inc, and Pai Holdings Pharm, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for edrophonium chloride.
Summary for edrophonium chloride
US Patents: | 0 |
Tradenames: | 6 |
Applicants: | 5 |
NDAs: | 6 |
Drug Master File Entries: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Patent Applications: | 9,715 |
DailyMed Link: | edrophonium chloride at DailyMed |
Medical Subject Heading (MeSH) Categories for edrophonium chloride
US Patents and Regulatory Information for edrophonium chloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Usa Inc | REVERSOL | edrophonium chloride | INJECTABLE;INJECTION | 089624-001 | May 13, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | EDROPHONIUM CHLORIDE | edrophonium chloride | INJECTABLE;INJECTION | 040131-001 | Feb 24, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | EDROPHONIUM CHLORIDE PRESERVATIVE FREE | edrophonium chloride | INJECTABLE;INJECTION | 040043-001 | Mar 20, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Institutional | ENLON | edrophonium chloride | INJECTABLE;INJECTION | 088873-001 | Aug 6, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |